Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qixin Zhao

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
ACS Applied Materials & Interfaces|December 5, 2025
Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer TreatmentQixin Zhao, Rui Zeng, Tao Bi, et al.
Journal of Translational Medicine|November 13, 2025
Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial-mesenchymal transition in chronic hepatic injuryBingwen Zhu, Xiyu Dai, Chunyan Liu, et al.
Journal of Medicinal Chemistry|March 6, 2025
Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species-Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver InjuryTao Bi, Pan Liang, Qixin Zhao, et al.
Nature Chemistry|June 1, 2026
Cation-directed assembly and sequential functionalization enable superprotonic polyanion-organic frameworks for high-power fuel cellsQixin Zhao, Bo Li, Dhruv Menon, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
ACS Applied Materials & Interfaces|December 5, 2025
Synergistic Proteolysis Targeting Chimera Chemotherapy Conjugate for Potent Non-small Cell Lung Cancer TreatmentQixin Zhao, Rui Zeng, Tao Bi, et al.
Journal of Translational Medicine|November 13, 2025
Betulinic acid as a novel AT1R inhibitor: attenuation of liver fibrosis via modulation of endothelial-mesenchymal transition in chronic hepatic injuryBingwen Zhu, Xiyu Dai, Chunyan Liu, et al.
Journal of Medicinal Chemistry|March 6, 2025
Targeted Degradation of Bromodomain-Containing Protein 4 Enabled by Reactive Oxygen Species-Activatable NanoPROTACs as an Efficient Strategy to Reverse Liver Fibrosis in Chronic Liver InjuryTao Bi, Pan Liang, Qixin Zhao, et al.
Nature Chemistry|June 1, 2026
Cation-directed assembly and sequential functionalization enable superprotonic polyanion-organic frameworks for high-power fuel cellsQixin Zhao, Bo Li, Dhruv Menon, et al.
Pageof 2